Cancer patients can respond very differently to the same treatment, while current testing may not reliably identify the therapy most likely to work for each tumor.
R&D Focus
Radiopharmaceutical diagnostics and targeted radioligand therapy
Innovative Solution
Jingjiahang is a cutting-edge biopharmaceutical company dedicated to the pioneering research, development, and commercialization of innovative new targeted radiopharmaceuticals. With a deep commitment to advancing precision medicine, Jingjiahang focuses on creating highly effective therapeutic solutions that are specifically designed to target and treat various types of cancer and other serious diseases.
Investment Funding
Last Funding Stage
Angel
Last Funding Date
13-06-2025
Startup Stage
Seed
Lead Investors
Hangzhou Binjiang 5050 Fund, Hangshi Asset Management, Zhengjing Capital
About
Jingjiahang is a cutting-edge biopharmaceutical company dedicated to the pioneering research, development, and commercialization of innovative new targeted radiopharmaceuticals. With a deep commitment to advancing precision medicine, Jingjiahang focuses on creating highly effective therapeutic solutions that are specifically designed to target and treat various types of cancer and other serious diseases.
Something missing or incorrect on this page? Help us enrich this information
